Santhera Pharmaceuticals Holding AG (SPHDF)
OTCMKTS · Delayed Price · Currency is USD
12.28
0.00 (0.00%)
Oct 20, 2025, 8:00 PM EDT
SPHDF Market Cap
SPHDF has a market cap or net worth of $171.91 million as of October 22, 2025. Its market cap has increased by 34.93% in one year.
Market Cap
171.91M
Enterprise Value
200.63M
Revenue
61.63M
Ranking
n/a
PE Ratio
n/a
Stock Price
$12.28
Market Cap Chart
Since November 3, 2006, SPHDF's market cap has decreased from 284.68M to 171.91M, a decrease of -39.61%. That is a compound annual growth rate of -2.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2025 | 166.40M | -9.79% |
| Dec 30, 2024 | 184.46M | 71.97% |
| Dec 29, 2023 | 107.26M | 31.69% |
| Dec 30, 2022 | 81.45M | 33.38% |
| Dec 30, 2021 | 61.07M | 0.06% |
| Dec 30, 2020 | 61.03M | -53.10% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 806.69M |
| Glass House Brands | 663.09M |
| Elite Pharmaceuticals | 636.35M |
| Northwest Biotherapeutics | 340.56M |
| Silence Therapeutics | 339.61M |
| Nika Pharmaceuticals | 335.28M |
| CytoDyn | 326.28M |
| American Oncology Network | 293.21M |